Eli Lilly to Acquire Centessa Pharmaceuticals for up to $7.8 Billion to Advance Sleep-Wake Treatments

Intelligence Brief:Eli Lilly to Acquire Centessa Pharmaceuticals for up to $7.8 Billion to Advance Sleep-Wake TreatmentsBiogen Acquires Apellis Pharmaceuticals for $5.6 BillionBolstering Immunology and Rare Disease PortfolioHHS Reverses Biden-era Tech ReorganizationReinstates ONC Name and Centralizes AIDataand Cybersecurity Under CIOSalus Deploys AI-Powered Medication Safety Platform at Houston MethodistCMS Delays Enforcement of Hospital Price Transparency Revisions until April 12026**(Intro Music fades)** **Alex:** Welcome back to Healthcare Daily Pulse, your rapid-fire dive into the most impactful shifts across the healthcare ecosystem. I’m Alex, your resident skeptic and payor P&L analyst. **Sam:** And I’m Sam, your market visionary, looking beyond the balance sheet to the strategic plays and competitive advantages. Today, we've got five blockbuster stories, packed with technical detail and market implications, all breaking within the last 48 hours. Let's not waste a s...